Study finds high levels of vitamin D needed for bone density drugs to workTo fully optimize a drug therapy for osteoporosis and low bone mineral density, patients should maintain vitamin D levels above the limits recently recommended by the Institute of Medicine, according to a new study by ...
DAVID F.ARCHER, inTreatment of the Postmenopausal Woman (Third Edition), 2007 6BONE MINERAL DENSITY COCs have been reported to enhancebone mineral density(BMD) in older women (30–34). This attribute would make them a logical choice forperimenopausal womenwho need to have a “bone bank” of...
BPs can induce osteoclast apoptosis, thereby inhibiting bone resorption.162BP treatment significantly increases bone mineral density in patients with osteoporosis by promoting bone healing, suppressing bone turnover and enhancing bone remodelling.163,164,165Among the BP family drugs, oral administration of ...
fracture risk, but cannot identify individuals who will have a fracture5. A limitation more associated with therapy screening, is the fact that DXA measurements do not reveal the effect of several treatment drugs. Most of the patients taking bisphosphates as treatment for osteoporosis are recorded ...
Changes in body composition may correlate with bone mineral density fluctuations in non-dialysis-dependent chronic kidney disease, according to a cohort study. Headline News ‘It’s not mental health’: Experts attribute rise in mass violence to ‘hate and anger’ ...
PurposeLong-term antiepileptic drug use is associated with low bone mineral density (BMD), fractures and abnormalities in bone metabolism. We aimed at determining the prevalence of bone mineral disorders in patients with refractory epilepsy treated with antiepileptic drugs.MethodsA cross-sectional survey...
There has been considerable discussion about how long to treat with bisphosphonates, because these drugs accumulate in the skeleton, leading to a reservoir that continues to be released for months or years after treatment has stopped. These medications also result in a low bone turnover state over...
If your test results are normal and you do not belong to the high risk group, you can repeat bone mineral density test once in 2-3 years. However, patients who are in the high risk group or under treatment for osteoporosis, bone density test is repeated every year or as advised by the...
Osteoporosis is a global health problem for ageing populations. The goals of osteoporosis treatment are to improve bone mineral density (BMD) and prevent fractures. One major obstacle that remains a great challenge to achieve the goals is how to select t
et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat. Genet. 27, 84–88 (2001). CAS PubMed Google Scholar Wozney, J. M. & Rosen, V. in Physiology and Pharmacology of Bone 725–748 (Springer, 1993). Hernigou, P., Poignard, A., Beaujean, F. & ...